Table 2 Comparison of median and IQR hospital LOS for specified conditions (MDC) for the years 1998/1999 and for the years 2010/2011; mean annual change in the period 1998–2011 based on the slope of the regression line adjusted for sex and age group, and its deviation from zero
MDC | Description | N of patients (1998–2011) | Median hospital LOS (IQR) in 1998/1999 | Median hospital LOS (IQR) in 2010/2011 | Mann Whitney U test | Slope (±S D) | Deviation from zero p-value, sex- and age-adjusted |
|---|---|---|---|---|---|---|---|
All the patients | 22649 | 10 (6–18) | 10 (6–18) | 0.20 | −0.02 ± 0.02 | 0.36b | |
01 | D&D of the nervous system | 645 | 12 (7–18) | 14 (8–20.5) | 0.23 | 0.23 ± 0.12 | 0.06b |
02 | D&D of the eye | 59 | 8 (5.5-18.5) | 9 (5–18) | 1.00 | / | / |
03 | D&D of the ear. nose. mouth and throat | 327 | 6 (4.5-8) | 6 (3–10) | 0.86 | 0.003 ± 0.09 | 0.97b |
04 | D&D of the respiratory system | 2565 | 10 (6–17) | 9 (6–15) | 0.42 | −0.07 ± 0.06 | 0.24b |
05 | D&D of the cardiovascular system | 428 | 9.5 (5–19) | 16.5 (9–42) | 0.0006 | 1.47 ± 0.24 | <0.0001 a |
06 | D&D of the digestive system | 923 | 8 (4–13) | 11 (6–17) | 0.0015 | 0.002 ± 0.09 | 0.98b |
07 | D&D of liver. gallbladder and pancreas | 2980 | 11 (6–18) | 9 (5–14) | 0.0018 | −0.24 ± 0.05 | <0.0001 b |
08 | D&D of the musculoskeletal system and connective tissue | 619 | 15 (8–22) | 19.5 (11.5-33) | 0.0091 | 0.2 ± 0.21 | 0.32b |
09 | D&D of the skin. subcutaneous tissue and breast | 865 | 7 (4–11) | 10 (6–17) | 0.0001 | 0.17 ± 0.09 | 0.06b |
10 | Endocrine. nutritional and metabolic diseases and disorders | 70 | 8 (6–11.5) | 8.5 (4.5-10.5) | 0.95 | / | / |
11 | D&D of the kidney and urinary tract | 423 | 8 (5.5-14.5) | 9 (5–15) | 0.95 | −0.20 ± 0.15 | 0.17b |
12 | D&D of the male reproductive tract | 62 | 8 (5.5-14) | 8 (5.5-10.5) | 0.90 | −0.47 ± 0.39 | 0.24 |
13 | D&D of the female reproductive tract | 29 | 12 (3.5-21.5) | 14 (8.5-20.5) | 0.79 | / | / |
14 | Pregnancy, childbirth and puerperium | 2 | / | / | / | / | / |
15 | D&D of the neonatal period | 1 | / | / | / | / | / |
16 | D&D of blood. myelopoietic and immune system | 214 | 10 (7-229 | 11 (6.5-18) | 0.61 | −0.25 ± 0.18 | 0.16 |
17 | Diseases and myeloproliferative disorders and poorly differentiated tumors | 374 | 4 (2–15) | 9.5 (5–16.5) | 0.06 | 0.003 ± 0.20 | 0.99 |
18 | Infectious and parasitic diseases (systemic or unspecified sites) | 2811 | 7 (4–11) | 9 (5–20) | <0.0001 | 0.26 ± 0.05 | <0.0001 b |
19 | Diseases and Mental Disorders | 27 | 7 (4–14) | / | / | / | / |
20 | Abuse of alcohol / drug induced organic mental disorders | 27 | 3.5 (2.5-8.5) | / | / | / | / |
21 | Injury. poisoning and toxic effects of drugs | 124 | 5.5 (3–10) | 8 (4.5-28) | 0.06 | 0.75 ± 0.35 | 0.034 |
22 | Burns | 2 | / | / | / | / | / |
23 | Factors influencing health status and use of health services | 53 | 7 (3–9) | / | / | / | / |
24 | Multiple relevant trauma | 3 | / | / | / | / | / |
25 | HIV infection | 8870 | 12 (7–22) | 10 (6–18) | 0.0044 | −0.19 ± 0.04 | <0.0001 |
Pre MDC | 76 | 53 (11–69) | 55.5 (24.5-74) | 0.95 | / | / | |
other DRG | 70 | 18 (17–22) | / | / | / | / |